| Q36581735 | A review of stroke in patients with hypertension and coronary artery disease: Focus on calcium channel blockers. |
| Q36973943 | ALDH2 protects against stroke by clearing 4-HNE. |
| Q36208448 | Adherence to a Mediterranean diet and prediction of incident stroke |
| Q37121372 | Age and follow-up time affect the prognostic value of the ECG and conventional cardiovascular risk factors for stroke in adult men |
| Q34086707 | Animal models of ischemic stroke. Part one: modeling risk factors |
| Q36143158 | Association between phosphodiesterase 4D gene and ischaemic stroke |
| Q36510299 | Association of Exhaled Carbon Monoxide With Stroke Incidence and Subclinical Vascular Brain Injury: Framingham Heart Study |
| Q37537746 | Can Orthopantomography be used as a tool for screening of carotid atheromatous pathology and thus be used to help reduce the prevalence of ischemic stroke within the population? |
| Q26824825 | Cardiovascular risk factors for acute stroke: Risk profiles in the different subtypes of ischemic stroke |
| Q37422931 | Cardiovascular, rheumatologic, and pharmacologic predictors of stroke in patients with rheumatoid arthritis: a nested, case-control study |
| Q33877253 | Cilostazol minimizes venous ischemic injury in diabetic and normal rats |
| Q37887815 | Clopidogrel hydrogen sulphate for atrial fibrillation |
| Q30843700 | Control of main risk factors after ischaemic stroke across Europe: data from the stroke-specific module of the EUROASPIRE III survey |
| Q45231287 | Differences between hypertensive and non-hypertensive ischemic stroke |
| Q50561153 | Do novel risk biomarkers reflect the severity of peripheral arterial disease? |
| Q36572955 | Effective management of hypertension with dihydropyridine calcium channel blocker-based combination therapy in patients at high cardiovascular risk |
| Q46410618 | Geospatial patterns of hospitalization rates for stroke with comorbid hypertension in relation to environmental sources of persistent organic pollutants: results from a 12-year population-based study |
| Q33705868 | Homocysteine and vascular disease |
| Q37277235 | How much can be gained by more systematic prevention of stroke? |
| Q35107196 | Increased risk of stroke after septicaemia: a population-based longitudinal study in Taiwan |
| Q54460447 | Interleukin-1 receptor antagonist gene polymorphism and susceptibility to ischemic stroke. |
| Q33377333 | Measuring holotranscobalamin II, an early indicator of negative vitamin B12 balance, by radioimmunoassay in patients with ischemic cerebrovascular disease |
| Q38391023 | Migraine and risk of ischaemic heart disease: a systematic review and meta-analysis of observational studies. |
| Q34775417 | Mixed dementia: epidemiology, diagnosis, and treatment |
| Q35159692 | Modifiable etiological factors and the burden of stroke from the Rotterdam study: a population-based cohort study |
| Q39658286 | Multiple modifiable risk factors for first ischemic stroke: a population-based epidemiological study |
| Q38083476 | Multivariable analysis in cerebrovascular research: practical notes for the clinician |
| Q37496707 | MyRisk_Stroke Calculator: A Personalized Stroke Risk Assessment Tool for the General Population |
| Q33389669 | Nephritis and the risk of acute myocardial infarction in patients with systemic lupus erythematosus |
| Q37166606 | Phosphodiesterase 4D gene and risk of noncardiogenic ischemic stroke in a Korean population. |
| Q35818904 | Prevention and treatment of stroke in patients with hypertension |
| Q34339048 | Primary stroke prevention |
| Q84772802 | Public health strategies could reduce the global stroke epidemic |
| Q37051963 | Regional differences in diabetes as a possible contributor to the geographic disparity in stroke mortality: the REasons for Geographic And Racial Differences in Stroke Study |
| Q36307679 | Secondhand Smoke Exposure and Stroke: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study |
| Q26801284 | Sex differences in predictors of ischemic stroke: current perspectives |
| Q33564681 | Statistical evaluation of adding multiple risk factors improves Framingham stroke risk score |
| Q28279570 | Stroke |
| Q92478777 | Structural Equation Model (SEM) of Stroke Mortality in Spanish Inpatient Hospital Settings: The Role of Individual and Contextual Factors |
| Q37459128 | The potential impact of primary headache disorders on stroke risk |
| Q47733400 | The potential impact of sleep-related movement disorders on stroke risk: a population-based longitudinal study |
| Q48353931 | Vascular dementia: a contemporary review of epidemiology, diagnosis, prevention, and treatment |
| Q30979218 | Where will the next generation of stroke treatments come from? |
| Q73446107 | [Different vascular risk factor profiles in ischemic stroke versus intracerebral hemorrhage: a study in 1,702 consecutive patients with acute stroke] |
| Q74064749 | [Guidelines for action and diagnosis in atherothrombosis in Spain: ADA Study (Action and Diagnosis in Atherothrombosis)] |
| Q73446170 | [Progress in the knowledge on endothelial dysfunction and its application in clinical practice] |